SI-BONE, Inc. announced its financial results for the second quarter ended June 30, 2025, on August 4, 2025. The company reported worldwide revenue of $48.6 million, a 21.7% increase from the prior year period, with U.S. revenue growing 22.8% to $46.4 million.
The company achieved its third consecutive quarter of positive adjusted EBITDA, reaching $1.0 million in Q2 2025, a significant improvement from a $2.7 million loss in Q2 2024. Critically, SI-BONE also achieved cash flow breakeven in the second quarter, ahead of its original timeline, with net cash generated of $1.1 million.
SI-BONE raised its 2025 worldwide revenue guidance to a range of $195 million to $198 million, implying year-over-year growth of 17% to 18%. The company also increased its full-year 2025 gross margin estimate to between 78.5% and 79.0%, while maintaining its expectation for positive adjusted EBITDA for the full year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.